Common heart medications are not secretly tied to an increased risk of dementia; rather, managing cardiovascular conditions with these medications often helps reduce dementia risk, especially when controlling factors like high blood pressure. However, certain types of medications, particularly some with anticholinergic properties, have been linked to increased dementia risk, but these are not typically the standard heart medications used for conditions like hypertension or heart disease.
High blood pressure (hypertension) is a well-established risk factor for dementia, including Alzheimer’s disease and vascular dementia. Research shows that aggressively controlling blood pressure with medications and lifestyle changes can significantly lower the risk of developing dementia. For example, a large randomized trial involving nearly 34,000 participants with uncontrolled hypertension found that those who achieved blood pressure control below 130/80 mm Hg had a 15% lower chance of being diagnosed with dementia over four years compared to those who did not receive intensive treatment[1]. This suggests that heart medications used to manage blood pressure are protective rather than harmful in terms of dementia risk.
Transient ischemic attacks (TIAs), often related to cardiovascular disease, also increase the risk of dementia. Studies adjusting for multiple risk factors found that people who experienced a TIA had nearly double the risk of developing dementia compared to those without TIA, even when stroke was excluded as an intermediary event[2]. This highlights the close link between cardiovascular health and cognitive decline, reinforcing the importance of heart medications in potentially reducing dementia risk by preventing such vascular events.
On the other hand, some medications commonly prescribed for various conditions, including certain heart-related symptoms, may increase dementia risk if they have anticholinergic effects. Anticholinergic drugs block acetylcholine, a neurotransmitter important for memory and learning. Long-term use of strong anticholinergic medications has been associated with a significantly higher risk of dementia in large population studies[3]. Examples include some antihistamines, tricyclic antidepressants, and medications for overactive bladder, but these are not the typical first-line heart medications like beta-blockers, ACE inhibitors, or statins.
Regarding statins and other lipid-lowering drugs, the relationship with dementia is complex. While these drugs reduce cardiovascular events, which should theoretically lower dementia risk, some studies suggest that longer life expectancy due to successful cardiovascular treatment might increase the chance of developing dementia simply because people live longer[4]. However, the overall evidence supports that managing cardiovascular risk factors—including with medications—helps prevent or delay dementia onset.
Moreover, addressing cardiometabolic diseases such as diabetes, hypertension, hyperlipidemia, stroke, and heart failure could prevent a substantial proportion of dementia cases—up to 37% according to some research[5]. This further underscores the protective role of heart medications in dementia prevention.
Current research is also exploring whether some heart medications might directly treat or slow vascular dementia. Trials are underway to test drugs in people who have had strokes to see if these medications can improve memory and thinking, potentially leading to new dementia treatments[6].
In summary, the evidence strongly supports that common heart medications used to control blood pressure, cholesterol, and other cardiovascular risks are generally beneficial in reducing dementia risk. The main caution is with medications that have anticholinergic effects, which are a different class and not the standard heart drugs. Maintaining cardiovascular health through appropriate medication and lifestyle changes remains a key strategy to lower the risk of dementia.
—
[1] AARP, “Can High Blood Pressure Cause
